Navigation Links
NW Bio 2012 Annual Report Shows Strong Progress And Enhancement Of Leadership Position
Date:4/8/2013

ive translation adjustment(190)(150)Total stockholders' deficit(16,073)(52,173)Total liabilities, redeemable common stock and stockholders' deficit$

7,570$

212 

 NORTHWEST BIOTHERAPEUTICS, INC.(A Development Stage Company)CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data)Years Ended December 31,Period from
Inception (March 18,
1996) to20122011December 31, 2012Revenues:Research material sales$

-$

10$

580Contract research and development from related parties--1,128Research grants and other772-1,833Total revenues772103,541Operating cost and expenses:Cost of research material sales--382Research and development28,90813,452119,172General and administration15,67513,33590,999Depreciation and amortization14102,377Loss on facility sublease--895Asset impairment loss--2,445Total operating costs and expenses44,59726,797216,270Loss from operations(43,825)(26,787)(212,729)Other income (expense):Valuation of reclassified equity instruments4918,82116,071Conversion inducement expense(9,103)(7,944)(27,337) Accretion of redeemable securities(2,042)-(2,042)Derivative valuation gain/(loss)6017281,383Gain on sale of intellectual property and property and equipment--3,664Interest expense(13,442)(7,648)(55,006)Interest income and other--1,707Net loss(67,320)(32,830)(274,289)Issuance of common stock in connection with elimination of Series A and Series A-1  preferred stock preferences--(12,349)Modification of Series A preferred stock warrants--(2,306)Modification of Series A-1 preferred stock warrants--(16,393)Series A preferred stock dividends--(334)Series A-1 preferred stock dividends--(917)Warrants issued on Series A and Series A-1 preferred stock dividends--(4,664)Accretion of Series A preferred stock mandatory redemption obligation--(1,872)Series A preferred stock redemption fee--(1,700)Beneficial conversion feature of Series D preferred stock--(4,274)Net loss applicable to common stock
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. DIA 2013 49th Annual Meeting to Address Hot Topics Surrounding Patient Therapies
2. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
3. Susan Cain Will Kick Off 2013 ASAE Annual Meeting & Exposition, Dan Heath is Closing General Session Speaker
4. Electronic Headband That Detects and Treats Addictive In-Sleep Behavior to be Demonstrated at Annual Holistic Dental Conference by Holistic Technologies
5. Professional Pricing Society Explores New Role of Pricers as Change Agents and Leaders at 24th Annual Spring Conference
6. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
7. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
8. Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
9. Archimedes Inc. Renews Annual Marketing Agreement with HealthEconomics.Com
10. Palatin Technologies To Present At The 25th Annual ROTH Conference
11. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 Charm Sciences, ... Department of Agriculture (USDA), Grain Inspection, Packers and ... contract to Charm Sciences to monitor aflatoxin in ... (water-based) and ROSA FAST Aflatoxin Quantitative Test (solvent-based). ... Test uses Water Extraction Technology to extract ...
(Date:5/22/2015)... 22, 2015 Knowledgent , the ... that explores the potential of big data analytics in ... was developed to help life sciences and healthcare organizations ... to gain critical business insights. , The life sciences ... data driven by patient profiling, compliance and regulatory requirements, ...
(Date:5/22/2015)... 22, 2015 Baylor Research Institute (BRI) ... Genomics Research Institute (TGen) in Phoenix, AZ ... accelerating early detection and treatments for patients with a broad ... will lead to new clinical trials and access to technology ... gap from bench to bedside across Baylor Scott ...
(Date:5/21/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... proprietary technologies and products for advanced microarray diagnostics, today ... fiscal quarter ended March 31, 2015. ... with our existing customers and to develop new opportunities," ... SQI. "The delivery of a fully automated sqidlite™ system ...
Breaking Biology Technology:USDA-GIPSA (FGIS) Awards 5 Year Contract for Aflatoxin Tests to Charm Sciences 2New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8
... TOWN, South Africa, Oct. 11, Iomai Corporation (Nasdaq: ... Glenn, M.D., presented an,overview of the clinical data for ... a vaccine could have on,global health at the Keystone ... Town, South Africa. Last month, Dr. Glenn presented ...
... quarter of 2007 increased 25 percent compared to the third quarter ... ... (NYSE: CRY ),a biomaterials, medical device and tissue processing company, ... 2007 were approximately $21.9 million compared to $20.0 million in the,third ...
... Genome Sciences (UK),Ltd "OGeS" announces today that it ... the appointment of Sir Walter Bodmer, currently,Head of ... of Molecular Medicine at the University of Oxford, ... changes which,lead to the development of colorectal cancer. ...
Cached Biology Technology:Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers' Diarrhea Patch at Keystone Conference 2Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers' Diarrhea Patch at Keystone Conference 3Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers' Diarrhea Patch at Keystone Conference 4CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 2CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 3CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 4CryoLife Announces Preliminary Third Quarter 2007 Revenues of Approximately $21.9 Million 5Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board 2Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board 3
(Date:5/21/2015)... According to a new ... Software, Services), by Applications (Surveillance (Airborne, Maritime, Land), ... (Military & Defense & Commercial) - Global Forecast ... is expected to grow from $7252.0 Million in ... Compound Annual Growth Rate (CAGR) of 6.6%. ...
(Date:5/21/2015)... 21, 2015 The Sync Project™ , ... for health, today announced a collaborative partnership with ... will center on collaboration on original research, joint course ... in the collaboration, The Sync Project and BerkleeICE are ... Medicine" in the 2015-2016 academic year.  ...
(Date:5/20/2015)... May 20, 2015 ... has announced the addition of the  ... Iris Recognition Market"  report to their ... research service analyses trends in the ... and commercial sectors, globally. Despite hardware ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2
... Tech in the United States have determined the structure ... xanthurenic acid (XA) in Anopheles gambiae, the malaria carrying ... reproduction of the malaria parasite (Plasmodium falciparum) in A. ... be an avenue for development of drugs and insecticides ...
... show that regular use of popular prescription pain relievers may ... percent and may offer similar benefit in the prevention of ... were released today at the annual meeting of the American ... believe this is the first study to show that selective ...
... Have you ever tried to do the limbo? For ants ... Zurich have discovered that ants are able to learn how ... they can successfully crawl under it without slowing down. Tobias ... Annual Meeting for the Society for Experimental Biology on Tuesday ...
Cached Biology News:Oxidation defense in mosquitoes benefits malaria parasite 2COX-2 inhibitors significantly reduce risk of cancer 2
... GeneMaths XT is undoubtedly the most complete ... advanced concept of layers and subsets makes ... layers for different data outputs, for example ... etc., as well as different subsets of ...
...
...
... for Mac OS X provides the most ... protein sequence analysis and molecular biology data ... 1). With Vector NTI Suite you can ... publicize diverse types of molecular biology data ...
Biology Products: